Get the Stockscreener App
0.00
100.00%
-21.64
Avadel Pharmaceuticals Plc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$21.64
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$2.12B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
0.00
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
0.00 | 2.12B | 221.08M | -2.92M | 5.89M | -0.033 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War - MSN
Pullback Watch: Should I hold or sell Avadel Pharmaceuticals plc now2025 Market Trends & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Avadel Merger Finalized as Market Focus Shifts to Clinical Pipeline - AD HOC NEWS
Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector with a Promising 54.9% Revenue Growth - DirectorsTalk Interviews
Quarterly Risk: Is Avadel Pharmaceuticals plc a good stock for dollar cost averaging2025 AllTime Highs & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
How Avadel Pharmaceuticals Plc (AVDL) Affects Rotational Strategy Timing - Stock Traders Daily
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Cross Above 200-Day Moving Average – What’s Next? - Defense World
Is Avadel Pharmaceuticals plc vulnerable to short sellers2025 Top Gainers & Short-Term Trading Opportunity Alerts - mfd.ru
Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating a 54.9% Revenue Growth Amidst Analyst Caution - DirectorsTalk Interviews
Best Pharmaceutical Stocks To Follow Now – February 17th - Defense World
Weiss Asset funds cash out 11.1M Avadel (AVDL) shares in Alkermes deal - Stock Titan
Mid Cap Stocks To Follow NowFebruary 18th - MarketBeat
Best Pharmaceutical Stocks To Watch TodayFebruary 18th - MarketBeat
Avadel (AVDL) stock: new SEC filing as shares stay suspended after $21 Alkermes buyout - Bez Kabli
Two Seas Capital reports 0% ownership in Avadel Pharmaceuticals (AVDL) - Stock Titan
Top Mid Cap Stocks To ConsiderFebruary 17th - MarketBeat
Best Pharmaceutical Stocks To Follow NowFebruary 17th - MarketBeat
Ireland's Alkermes plc buys Avadel Pharmaceuticals plc - ALCHEMPro
3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value - simplywall.st
Avadel Pharmaceuticals plc acquired by Alkermes plc - Arthur Cox LLP
FOMO Trade: Is Avadel Pharmaceuticals plc vulnerable to short sellersJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Alkermes Completes $2.1 Billion Acquisition of Avadel Pharmaceuticals - CHEManager
Best Pharmaceutical Stocks To Follow TodayFebruary 13th - MarketBeat
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Short Interest Down 36.0% in January - MarketBeat
Alkermes plc completes acquisition of Avadel Pharmaceuticals plc, accelerating entry into sleep medicine market - marketscreener.com
Pharmaceutical Stocks To Watch TodayFebruary 12th - MarketBeat
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - BioSpace
Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market - TradingView
Alkermes PLC has successfully completed the acquisition of Avadel Pharmaceuticals plc. - Bitget
Alkermes Acquires Avadel Pharmaceuticals - Contract Pharma
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Alkermes Completes Acquisition and Delisting of Avadel Pharmaceuticals - TipRanks
Avadel Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Alkermes (Nasdaq: ALKS) closes Avadel acquisition, adds LUMRYZ and $1.5B loans - Stock Titan
RFG Advisory LLC Acquires New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
(AVDL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Growth Recap: Is Avadel Pharmaceuticals plc stock a falling knife or bargain buyQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Form 8.3 -Avadel Pharmaceuticals plc - The Manila Times
Will Avadel Pharmaceuticals plc stock recover faster than market2025 Fundamental Recap & Weekly Sector Rotation Insights - mfd.ru
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes - TipRanks
Avadel Pharmaceuticals plc(NasdaqGM: AVDL) dropped from Russell 3000E Growth Index - marketscreener.com
Alkermes (ALKS) Set to Finalize Acquisition of Avadel Pharmaceuticals - GuruFocus
Avadel Pharmaceuticals plc Announces High Court Approval of Scheme of Arrangement for Acquisition by Alkermes plc - Quiver Quantitative
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing - The Manila Times
Irish court clears Alkermes buyout; Avadel stock trading ends Feb. 11 - Stock Titan
Alkermes Increases Offer for Avadel Acquisition - MSN
Penserra Capital Management LLC Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Goldman Sachs (EPT)Form 38.5b- AVADEL PHARMACEUTICALS PLC - Research Tree
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Increase in Short Interest - MarketBeat
Macro Review: Will CMBT outperform tech stocksEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
3.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):